FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950332405> ?p ?o ?g. }

• W2950332405 endingPage "34" @default.
• W2950332405 startingPage "21" @default.
• W2950332405 abstract "Abstract Introduction: Smoking is a huge medical and social problem in Poland, with as many as about 24% of Poles being addicted to nicotine. Approximately 6 million people worldwide die every year from conditions that are closely related to tobacco addiction, such as cancer and cardiovascular, metabolic or lung diseases. The difficulty in combatting nicotine dependence is largely due to the complex mechanism of this addiction. The motivation of a patient to quit smoking is of great importance in the difficult withdrawal process. Strengthening this motivation is one of the most important tasks of physicians and addiction therapists. Overview of literature: Nicotine replacement therapy (NRT) has been the most widely known way to break away from smoking addiction for many years now. It involves delivering nicotine to the body in ways that are less harmful than through tobacco smoke. As a consequence, the cravings for nicotine are reduced, making it easier for the patient to break with the addiction. Clinical trials have shown that the use of NRT is associated with a 50-70% increased chance of maintaining abstinence from smoking compared to placebo. There are many NRT products, including nicotine chewing gum, nicotine patches, lozenges, dissolvable nicotine sticks, or inhalers. Bupropion is a selective dopamine–noradrenaline reuptake inhibitor. This drug is one of the most commonly used in the pharmacotherapy of depression in the United States. At the same time, it has been found to have a positive effect on people trying to break up with the habit of smoking cigarettes. The mechanism of action remains unknown in this case, but studies clearly indicate the efficacy of bupropion, which is comparable to the efficacy of NRT. Varenicline is a partial agonist selective for α4β2 nicotinic acetylcholine receptors. It has a higher affinity for these receptors than nicotine. By stimulating them, it causes an increase in dopamine secretion (but to a lesser extent than cigarette smoking), helping in this way ease withdrawal symptoms. Conclusions: Varenicline has higher efficacy than bupropion and NRTs. Simultaneous use of two NRT forms increases the effectiveness of this method to a level comparable to varenicline. Contrary to previous reports, it seems that varenicline does not increase self-aggressive behaviour and the risk of suicide. The effectiveness of antinicotinic drugs depends on the sex of the patient. For both sexes, the most effective drug is varenicline. It is slightly more effective in women than in men. By contrast, NRT and bupropion show greater therapeutic potential in men." @default.
• W2950332405 created "2019-06-27" @default.
• W2950332405 creator A5017596121 @default.
• W2950332405 creator A5020940425 @default.
• W2950332405 creator A5026848695 @default.
• W2950332405 creator A5034459673 @default.
• W2950332405 creator A5062316994 @default.
• W2950332405 creator A5086077583 @default.
• W2950332405 date "2019-03-01" @default.
• W2950332405 modified "2023-09-23" @default.
• W2950332405 title "Can the use of varenicline improve the efficacy of pharmacotherapy for nicotine addiction?" @default.
• W2950332405 cites W1496088628 @default.
• W2950332405 cites W1680848243 @default.
• W2950332405 cites W1794449622 @default.
• W2950332405 cites W1859891561 @default.
• W2950332405 cites W1955803833 @default.
• W2950332405 cites W1969626001 @default.
• W2950332405 cites W1976653331 @default.
• W2950332405 cites W1978524840 @default.
• W2950332405 cites W1979151914 @default.
• W2950332405 cites W1993112595 @default.
• W2950332405 cites W2008134472 @default.
• W2950332405 cites W2010137196 @default.
• W2950332405 cites W2016691339 @default.
• W2950332405 cites W2020972628 @default.
• W2950332405 cites W2023431702 @default.
• W2950332405 cites W2027587269 @default.
• W2950332405 cites W2032169775 @default.
• W2950332405 cites W2035191792 @default.
• W2950332405 cites W2035839366 @default.
• W2950332405 cites W2036168588 @default.
• W2950332405 cites W2051592959 @default.
• W2950332405 cites W2084289344 @default.
• W2950332405 cites W2092056730 @default.
• W2950332405 cites W2096221609 @default.
• W2950332405 cites W2107200746 @default.
• W2950332405 cites W2119675051 @default.
• W2950332405 cites W2120891721 @default.
• W2950332405 cites W2123239058 @default.
• W2950332405 cites W2127608961 @default.
• W2950332405 cites W2129754593 @default.
• W2950332405 cites W2130856431 @default.
• W2950332405 cites W2141859631 @default.
• W2950332405 cites W2143588078 @default.
• W2950332405 cites W2157000531 @default.
• W2950332405 cites W2164386461 @default.
• W2950332405 cites W2166328543 @default.
• W2950332405 cites W2317321545 @default.
• W2950332405 cites W2467951750 @default.
• W2950332405 cites W2472206766 @default.
• W2950332405 cites W2523036932 @default.
• W2950332405 cites W2527906916 @default.
• W2950332405 cites W2534447707 @default.
• W2950332405 cites W3006035094 @default.
• W2950332405 cites W4210565407 @default.
• W2950332405 cites W4237795005 @default.
• W2950332405 doi "https://doi.org/10.2478/cpp-2019-0002" @default.
• W2950332405 hasPublicationYear "2019" @default.
• W2950332405 type Work @default.
• W2950332405 sameAs 2950332405 @default.
• W2950332405 citedByCount "0" @default.
• W2950332405 crossrefType "journal-article" @default.
• W2950332405 hasAuthorship W2950332405A5017596121 @default.
• W2950332405 hasAuthorship W2950332405A5020940425 @default.
• W2950332405 hasAuthorship W2950332405A5026848695 @default.
• W2950332405 hasAuthorship W2950332405A5034459673 @default.
• W2950332405 hasAuthorship W2950332405A5062316994 @default.
• W2950332405 hasAuthorship W2950332405A5086077583 @default.
• W2950332405 hasBestOaLocation W29503324051 @default.
• W2950332405 hasConcept C118552586 @default.
• W2950332405 hasConcept C142724271 @default.
• W2950332405 hasConcept C2777053506 @default.
• W2950332405 hasConcept C2777843972 @default.
• W2950332405 hasConcept C2779177420 @default.
• W2950332405 hasConcept C2779547902 @default.
• W2950332405 hasConcept C2779908668 @default.
• W2950332405 hasConcept C2780478649 @default.
• W2950332405 hasConcept C2780687700 @default.
• W2950332405 hasConcept C2908647359 @default.
• W2950332405 hasConcept C3019190695 @default.
• W2950332405 hasConcept C48856860 @default.
• W2950332405 hasConcept C500440147 @default.
• W2950332405 hasConcept C62724370 @default.
• W2950332405 hasConcept C71924100 @default.
• W2950332405 hasConcept C98274493 @default.
• W2950332405 hasConcept C99454951 @default.
• W2950332405 hasConceptScore W2950332405C118552586 @default.
• W2950332405 hasConceptScore W2950332405C142724271 @default.
• W2950332405 hasConceptScore W2950332405C2777053506 @default.
• W2950332405 hasConceptScore W2950332405C2777843972 @default.
• W2950332405 hasConceptScore W2950332405C2779177420 @default.
• W2950332405 hasConceptScore W2950332405C2779547902 @default.
• W2950332405 hasConceptScore W2950332405C2779908668 @default.
• W2950332405 hasConceptScore W2950332405C2780478649 @default.
• W2950332405 hasConceptScore W2950332405C2780687700 @default.
• W2950332405 hasConceptScore W2950332405C2908647359 @default.
• W2950332405 hasConceptScore W2950332405C3019190695 @default.
• W2950332405 hasConceptScore W2950332405C48856860 @default.

• next